The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
ISHITADR Key Metrics
ISHITADR Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
ISHITADR Share Price
ISHITADR
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ISHITADR Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Low but stable operating margin
Low dividend yield
Neutral
Low ROE but improving trend
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0122527.
Snapshot
See detailed analysis
ISHITADR Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ISHITADR Bulk, Block & Insider Trades
ISHITADR Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Companys APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides a... Read More
Key personnel
Mr. Sumit Agrawal
Chief Financial Officer
Ms. Srushti Pandya
Compliance Officer, Company Secretary
Mr. Jagdishprasad AgrawalD
Managing Director, Executive Director
Mrs. Abha Jagdishprasad AgrawalD
Non-Executive Director
Mr. Arvind Vilasrao SapkalD
Non-Executive Independent Director
Ms. Dhwani SolankiD
Non-Executive Independent Director
Ms. Dhwani SolankiD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Ishita Drugs & Industries Ltd.?
The current share price of Ishita Drugs & Industries Ltd. is ₹ 75.10 as of 09 Jan 2026.
What is the PE ratio of Ishita Drugs & Industries Ltd.?
The Price-to-Earnings (PE) ratio of Ishita Drugs & Industries Ltd. is 23.11 as of the latest financial data.
What is the ROE and ROCE of Ishita Drugs & Industries Ltd.?
Ishita Drugs & Industries Ltd. has a Return on Equity (ROE) of 9.04% and a Return on Capital Employed (ROCE) of 7.91% as per the latest financial reports.
What is the market cap of Ishita Drugs & Industries Ltd.?
The market capitalization of Ishita Drugs & Industries Ltd. stands at ₹ 22.45 Cr.
What is the dividend yield of Ishita Drugs & Industries Ltd.?
The dividend yield of Ishita Drugs & Industries Ltd. is 0.00% based on the current market price.
What is the RSI of Ishita Drugs & Industries Ltd.?
The Relative Strength Index (RSI) of Ishita Drugs & Industries Ltd. is 48.33.
What is the FII and DII holding in Ishita Drugs & Industries Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Ishita Drugs & Industries Ltd. shares.
What sector does Ishita Drugs & Industries Ltd. belong to?
Ishita Drugs & Industries Ltd. operates in the Healthcare sector.
What is the beta of Ishita Drugs & Industries Ltd. stock?
The beta of Ishita Drugs & Industries Ltd. stock is -0.13, indicating its volatility relative to the broader market.
